1-4 of 4
Oleg Akilov
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-in-Human Phase 1a Clinical Trial of the Investigational New Drug ST-001, a Novel Nano-Phospholipid Dispersion Formulation of Fenretinide, in Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma

Ali Moiin, Yamini Donekal, Louis Scarmoutzos, Michael Burns, Robert Patterson, Earle Holsapple, III, Ajay K. Gopal, Ralph Parchment, Oleg Akilov
Journal: Blood
Blood (2024) 144 (Supplement 1): 4453.1.
https://doi.org/10.1182/blood-2024-211734
Published: 2024
Journal Articles

Mogamulizumab in Patients with Mycosis Fungoides/Sézary Syndrome: Preliminary Results from an Ongoing Phase 2, Open-Label, Multicenter, Single-Arm Study Assessing a 4-Weekly Dosing Schedule

Christiane Querfeld, Julia J Scarisbrick, Oleg Akilov, Payal Arora, Yi Liu, Martine Bagot, Raul Cordoba, Richard Cowan, Alejandro Martín García-Sancho, Larisa J Geskin, Auris O Huen, Jatin Jadwani, Steven Morris, Pablo L Ortiz-Romero, Akshaya Patel, Lauren C. Pinter-Brown, Ramon M Pujol, Pietro Quaglino, Nakhle S Saba, Ragini Vuppugalla, Henry Zhao, Youn H. Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 3056.
https://doi.org/10.1182/blood-2024-200596
Published: 2024
Journal Articles

Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies

Steven M. Horwitz, James M. Foran, Michael Maris, Jennifer Kimberly Lue, Ahmed Sawas, Craig Okada, Tatyana A. Feldman, Lubomir Sokol, Matthew Mei, Ian W. Flinn, Diego Villa, Mary-Elizabeth M. Percival, Deepa Jagadeesh, Kerry J. Savage, Oleg Akilov, Catherine S. Diefenbach, Youn H. Kim, Gloria H. Y. Lin, Tina Catalano, Penka S. Petrova, Bob Uger, Naomi Molloy, Kathleen Large, Ingmar Bruns, Stephen M. Ansell
Journal: Blood
Blood (2021) 138 (Supplement 1): 2448.
https://doi.org/10.1182/blood-2021-154490
Published: 2021
Journal Articles

Co-Inhibition of IL-2, IL-9 and IL-15 By the Novel Immunomodulator, Bnz-1, Provides Clinical Efficacy in Patients with Refractory Cutaneous T Cell Lymphoma in a Phase 1/2 Clinical Trial

Christiane Querfeld, MDPhD, Basem M. William, MDMRCP, Lubomir Sokol, MD PhD, Oleg Akilov, MD, Brian Poligone, MD PhD, Jasmine Zain, MD, Yutaka Tagaya, MD PhD, Nazli Azimi, PhD PharmD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37.
https://doi.org/10.1182/blood-2020-143135
Published: 2020